Abacus Health Products Receives New Purchase Orders from CVS and Four Additional Retail Chains

Published: April 12, 2019

Abacus Health Products, Inc. announced the latest round of purchase orders for their line of CBDMEDIC products. These new orders from five U.S. retail chains, including CVS Pharmacy, Weis Markets, and Pharmacare Inc., bring CBDMEDIC products to over 1,100 pharmacy and supermarket retail locations throughout the country.

“These new purchase orders demonstrate strong momentum and the successful execution of our retail growth strategy,” said Perry Antelman, CEO of Abacus. “Moving forward, we continue to identify and pursue opportunities to further expand the availability of our range of CBDMEDICâ„¢ products. We are providing new and innovative products for consumers seeking topical pain relief and therapeutic skincare treatment.”

The American Academy of Pain Medicine has estimated that chronic pain affects approximately 100 million Americans. Further, a 2018 research report by Allied Market Research estimated the global topical pain relief market to be approximately US$7.4 billion in 2017. According to the American Academy of Dermatology Association, a form of skin disease affects over 84 million Americans, with the total cost of those diseases including US$15 billion in prescription drugs and US$10 billion in over-the-counter products.